Nimodipine in migraine: clinical efficacy and endocrinological effects

R. Formisano, P. Falaschi, R. Cerbo, A. Proietti, T. Catarci, R. D'Urso, C. Roberti, V. Aloise, F. Chiarotti, A. Agnoli

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Serum prolactin is increased during chronic flunarizine treatment of patients suffering from migraine. In order to clarify the role of calcium in control of the secretion of anterior pituitary hormones, a study has now been made of the effects of chronic nimodipine and propranolol treatment of migraine patients on prolactin (PRL), luteinizing hormone (LH) and growth hormone (GH) levels. 11 patients were treated with nimodipine and 8 with propranolol for four months. A statistically significant reduction in the frequency of the attacks was demonstrated in both groups. No significant change was found in the hormones levels during nimodipine treatment.

Original languageEnglish
Pages (from-to)69-71
Number of pages3
JournalEuropean Journal of Clinical Pharmacology
Volume41
Issue number1
DOIs
Publication statusPublished - Jul 1991

Fingerprint

Nimodipine
Migraine Disorders
Propranolol
Prolactin
Anterior Pituitary Hormones
Flunarizine
Luteinizing Hormone
Growth Hormone
Therapeutics
Hormones
Calcium
Serum

Keywords

  • adverse effects
  • growth hormone
  • luteinizing hormone
  • Migraine
  • nimodipine
  • prolactin
  • propranolol

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Formisano, R., Falaschi, P., Cerbo, R., Proietti, A., Catarci, T., D'Urso, R., ... Agnoli, A. (1991). Nimodipine in migraine: clinical efficacy and endocrinological effects. European Journal of Clinical Pharmacology, 41(1), 69-71. https://doi.org/10.1007/BF00280110

Nimodipine in migraine : clinical efficacy and endocrinological effects. / Formisano, R.; Falaschi, P.; Cerbo, R.; Proietti, A.; Catarci, T.; D'Urso, R.; Roberti, C.; Aloise, V.; Chiarotti, F.; Agnoli, A.

In: European Journal of Clinical Pharmacology, Vol. 41, No. 1, 07.1991, p. 69-71.

Research output: Contribution to journalArticle

Formisano, R, Falaschi, P, Cerbo, R, Proietti, A, Catarci, T, D'Urso, R, Roberti, C, Aloise, V, Chiarotti, F & Agnoli, A 1991, 'Nimodipine in migraine: clinical efficacy and endocrinological effects', European Journal of Clinical Pharmacology, vol. 41, no. 1, pp. 69-71. https://doi.org/10.1007/BF00280110
Formisano, R. ; Falaschi, P. ; Cerbo, R. ; Proietti, A. ; Catarci, T. ; D'Urso, R. ; Roberti, C. ; Aloise, V. ; Chiarotti, F. ; Agnoli, A. / Nimodipine in migraine : clinical efficacy and endocrinological effects. In: European Journal of Clinical Pharmacology. 1991 ; Vol. 41, No. 1. pp. 69-71.
@article{30f9521fa916452ea0d20af02e42bacb,
title = "Nimodipine in migraine: clinical efficacy and endocrinological effects",
abstract = "Serum prolactin is increased during chronic flunarizine treatment of patients suffering from migraine. In order to clarify the role of calcium in control of the secretion of anterior pituitary hormones, a study has now been made of the effects of chronic nimodipine and propranolol treatment of migraine patients on prolactin (PRL), luteinizing hormone (LH) and growth hormone (GH) levels. 11 patients were treated with nimodipine and 8 with propranolol for four months. A statistically significant reduction in the frequency of the attacks was demonstrated in both groups. No significant change was found in the hormones levels during nimodipine treatment.",
keywords = "adverse effects, growth hormone, luteinizing hormone, Migraine, nimodipine, prolactin, propranolol",
author = "R. Formisano and P. Falaschi and R. Cerbo and A. Proietti and T. Catarci and R. D'Urso and C. Roberti and V. Aloise and F. Chiarotti and A. Agnoli",
year = "1991",
month = "7",
doi = "10.1007/BF00280110",
language = "English",
volume = "41",
pages = "69--71",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Nimodipine in migraine

T2 - clinical efficacy and endocrinological effects

AU - Formisano, R.

AU - Falaschi, P.

AU - Cerbo, R.

AU - Proietti, A.

AU - Catarci, T.

AU - D'Urso, R.

AU - Roberti, C.

AU - Aloise, V.

AU - Chiarotti, F.

AU - Agnoli, A.

PY - 1991/7

Y1 - 1991/7

N2 - Serum prolactin is increased during chronic flunarizine treatment of patients suffering from migraine. In order to clarify the role of calcium in control of the secretion of anterior pituitary hormones, a study has now been made of the effects of chronic nimodipine and propranolol treatment of migraine patients on prolactin (PRL), luteinizing hormone (LH) and growth hormone (GH) levels. 11 patients were treated with nimodipine and 8 with propranolol for four months. A statistically significant reduction in the frequency of the attacks was demonstrated in both groups. No significant change was found in the hormones levels during nimodipine treatment.

AB - Serum prolactin is increased during chronic flunarizine treatment of patients suffering from migraine. In order to clarify the role of calcium in control of the secretion of anterior pituitary hormones, a study has now been made of the effects of chronic nimodipine and propranolol treatment of migraine patients on prolactin (PRL), luteinizing hormone (LH) and growth hormone (GH) levels. 11 patients were treated with nimodipine and 8 with propranolol for four months. A statistically significant reduction in the frequency of the attacks was demonstrated in both groups. No significant change was found in the hormones levels during nimodipine treatment.

KW - adverse effects

KW - growth hormone

KW - luteinizing hormone

KW - Migraine

KW - nimodipine

KW - prolactin

KW - propranolol

UR - http://www.scopus.com/inward/record.url?scp=0025821529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025821529&partnerID=8YFLogxK

U2 - 10.1007/BF00280110

DO - 10.1007/BF00280110

M3 - Article

C2 - 1782981

AN - SCOPUS:0025821529

VL - 41

SP - 69

EP - 71

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 1

ER -